vs
ICU MEDICAL INC（ICUI）与SPORTSMAN'S WAREHOUSE HOLDINGS, INC.（SPWH）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是SPORTSMAN'S WAREHOUSE HOLDINGS, INC.的1.6倍（$540.7M vs $331.3M），SPORTSMAN'S WAREHOUSE HOLDINGS, INC.净利率更高（0.0% vs -2.9%，领先2.9%），SPORTSMAN'S WAREHOUSE HOLDINGS, INC.同比增速更快（2.2% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $8.7M），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -5.4%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
运动员仓库控股（Sportsman's Warehouse）是美国户外体育用品零售商，门店遍布全美29个州，主要面向狩猎、射击、露营、垂钓等各类户外休闲运动爱好者，销售户外服饰、鞋履及专业运动装备。
ICUI vs SPWH — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $331.3M |
| 净利润 | $-15.7M | $8.0K |
| 毛利率 | 37.5% | 32.8% |
| 营业利润率 | 1.0% | 1.3% |
| 净利率 | -2.9% | 0.0% |
| 营收同比 | -14.1% | 2.2% |
| 净利润同比 | 34.0% | -97.8% |
| 每股收益（稀释后） | $-0.63 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $540.7M | $331.3M | ||
| Q3 25 | $537.0M | $293.9M | ||
| Q2 25 | $548.9M | $249.1M | ||
| Q1 25 | $604.7M | $340.4M | ||
| Q4 24 | $629.8M | $324.3M | ||
| Q3 24 | $589.1M | $288.7M | ||
| Q2 24 | $596.5M | $244.2M | ||
| Q1 24 | $566.7M | $370.4M |
| Q4 25 | $-15.7M | $8.0K | ||
| Q3 25 | $-3.4M | $-7.1M | ||
| Q2 25 | $35.3M | $-21.3M | ||
| Q1 25 | $-15.5M | $-8.7M | ||
| Q4 24 | $-23.8M | $-364.0K | ||
| Q3 24 | $-33.0M | $-5.9M | ||
| Q2 24 | $-21.4M | $-18.1M | ||
| Q1 24 | $-39.5M | $-8.7M |
| Q4 25 | 37.5% | 32.8% | ||
| Q3 25 | 37.4% | 32.0% | ||
| Q2 25 | 37.9% | 30.4% | ||
| Q1 25 | 34.7% | 30.4% | ||
| Q4 24 | 36.1% | 31.8% | ||
| Q3 24 | 34.8% | 31.2% | ||
| Q2 24 | 34.8% | 30.2% | ||
| Q1 24 | 32.7% | 26.8% |
| Q4 25 | 1.0% | 1.3% | ||
| Q3 25 | 2.6% | -1.1% | ||
| Q2 25 | 1.9% | -7.9% | ||
| Q1 25 | 2.1% | 1.1% | ||
| Q4 24 | 6.0% | 1.0% | ||
| Q3 24 | 1.4% | -1.5% | ||
| Q2 24 | 1.3% | -8.4% | ||
| Q1 24 | -1.9% | -2.1% |
| Q4 25 | -2.9% | 0.0% | ||
| Q3 25 | -0.6% | -2.4% | ||
| Q2 25 | 6.4% | -8.5% | ||
| Q1 25 | -2.6% | -2.6% | ||
| Q4 24 | -3.8% | -0.1% | ||
| Q3 24 | -5.6% | -2.0% | ||
| Q2 24 | -3.6% | -7.4% | ||
| Q1 24 | -7.0% | -2.4% |
| Q4 25 | $-0.63 | $0.00 | ||
| Q3 25 | $-0.14 | $-0.18 | ||
| Q2 25 | $1.43 | $-0.56 | ||
| Q1 25 | $-0.63 | $-0.22 | ||
| Q4 24 | $-0.97 | $-0.01 | ||
| Q3 24 | $-1.35 | $-0.16 | ||
| Q2 24 | $-0.88 | $-0.48 | ||
| Q1 24 | $-1.63 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $2.2M |
| 总债务越低越好 | — | $44.0M |
| 股东权益账面价值 | $2.1B | $209.5M |
| 总资产 | $4.1B | $913.9M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $1.8M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $2.8M | ||
| Q4 24 | $308.6M | $2.7M | ||
| Q3 24 | $312.5M | $2.6M | ||
| Q2 24 | $302.6M | $2.2M | ||
| Q1 24 | $251.4M | $3.1M |
| Q4 25 | — | $44.0M | ||
| Q3 25 | — | $43.9M | ||
| Q2 25 | — | $24.1M | ||
| Q1 25 | — | $24.1M | ||
| Q4 24 | — | $24.0M | ||
| Q3 24 | — | $24.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.1B | $209.5M | ||
| Q3 25 | $2.1B | $208.9M | ||
| Q2 25 | $2.1B | $215.1M | ||
| Q1 25 | $2.0B | $235.7M | ||
| Q4 24 | $2.0B | $243.6M | ||
| Q3 24 | $2.0B | $243.0M | ||
| Q2 24 | $2.0B | $247.5M | ||
| Q1 24 | $2.1B | $264.6M |
| Q4 25 | $4.1B | $913.9M | ||
| Q3 25 | $4.1B | $948.9M | ||
| Q2 25 | $4.1B | $929.7M | ||
| Q1 25 | $4.2B | $852.1M | ||
| Q4 24 | $4.2B | $967.7M | ||
| Q3 24 | $4.3B | $901.9M | ||
| Q2 24 | $4.3B | $930.4M | ||
| Q1 24 | $4.3B | $886.2M |
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.10× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $16.3M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $8.7M |
| 自由现金流率自由现金流/营收 | 6.6% | 2.6% |
| 资本支出强度资本支出/营收 | 4.6% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 2038.00× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $-39.7M |
8季度趋势，按日历期对齐
| Q4 25 | $60.6M | $16.3M | ||
| Q3 25 | $56.7M | $-26.6M | ||
| Q2 25 | $11.2M | $-60.2M | ||
| Q1 25 | $51.3M | $52.8M | ||
| Q4 24 | $40.2M | $-2.5M | ||
| Q3 24 | $36.1M | $18.5M | ||
| Q2 24 | $82.0M | $-34.6M | ||
| Q1 24 | $45.8M | $68.9M |
| Q4 25 | $36.0M | $8.7M | ||
| Q3 25 | $27.6M | $-33.9M | ||
| Q2 25 | $-8.5M | $-64.0M | ||
| Q1 25 | $36.7M | $49.6M | ||
| Q4 24 | $16.1M | $-6.2M | ||
| Q3 24 | $16.2M | $14.1M | ||
| Q2 24 | $62.5M | $-38.0M | ||
| Q1 24 | $29.9M | $60.2M |
| Q4 25 | 6.6% | 2.6% | ||
| Q3 25 | 5.1% | -11.5% | ||
| Q2 25 | -1.5% | -25.7% | ||
| Q1 25 | 6.1% | 14.6% | ||
| Q4 24 | 2.6% | -1.9% | ||
| Q3 24 | 2.7% | 4.9% | ||
| Q2 24 | 10.5% | -15.5% | ||
| Q1 24 | 5.3% | 16.2% |
| Q4 25 | 4.6% | 2.3% | ||
| Q3 25 | 5.4% | 2.5% | ||
| Q2 25 | 3.6% | 1.5% | ||
| Q1 25 | 2.4% | 1.0% | ||
| Q4 24 | 3.8% | 1.1% | ||
| Q3 24 | 3.4% | 1.5% | ||
| Q2 24 | 3.3% | 1.4% | ||
| Q1 24 | 2.8% | 2.4% |
| Q4 25 | — | 2038.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
SPWH
暂无分部数据
